Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Cyproheptadine

😃Good
Catalog No. T60576Cas No. 129-03-3

Cyproheptadine is an orally active serotonin 5-HT2A receptor antagonist with multiple pharmacological properties including antidepressant, anti-serotonin, antiplatelet, and antithrombotic effects. Cyproheptadine is used as a research compound for investigating thromboembolic diseases, serotonergic signaling, and potential links between serotonin modulation and metabolic disorders such as diabetes.

Cyproheptadine

Cyproheptadine

😃Good
Purity: 99.92%
Catalog No. T60576Cas No. 129-03-3
Cyproheptadine is an orally active serotonin 5-HT2A receptor antagonist with multiple pharmacological properties including antidepressant, anti-serotonin, antiplatelet, and antithrombotic effects. Cyproheptadine is used as a research compound for investigating thromboembolic diseases, serotonergic signaling, and potential links between serotonin modulation and metabolic disorders such as diabetes.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$30-In Stock
2 mg$40-In Stock
5 mg$64-In Stock
10 mg$106-In Stock
25 mg$197-In Stock
50 mg$289-In Stock
100 mg$428-In Stock
200 mg$623-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.92%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Cyproheptadine is an orally active serotonin 5-HT2A receptor antagonist with multiple pharmacological properties including antidepressant, anti-serotonin, antiplatelet, and antithrombotic effects. Cyproheptadine is used as a research compound for investigating thromboembolic diseases, serotonergic signaling, and potential links between serotonin modulation and metabolic disorders such as diabetes.
In vitro
In in vitro experiments, Cyproheptadine (0.01–100 nM, 1 minute) dose-dependently inhibited serotonin-enhanced ADP-induced mouse platelet aggregation [2]; at a concentration of 10 nM, Cyproheptadine suppressed 15 μM serotonin-potentiated 1 μM ADP-induced platelet tyrosine phosphorylation [2]; Cyproheptadine also inhibited activation markers of homo sapiens platelets, including phosphatidylserine (PS) exposure (detected by annexin V), P-selectin (CD62P), and the GPIIb-IIIa complex (assessed via PAC-1 binding) [2].
In vivo
Cyproheptadine (1 mg/kg, intraperitoneal injection, once daily for 5 consecutive days) significantly prolonged the arterial occlusion time and tail bleeding time in C57BL/6 mice [2].
Chemical Properties
Molecular Weight287.4
FormulaC21H21N
Cas No.129-03-3
SmilesC=1C=CC2=C(C1)C=CC=3C=CC=CC3C2=C4CCN(C)CC4
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 2 mg/mL (6.96 mM), when pH is adjusted to 3 with HCl. Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4795 mL17.3974 mL34.7947 mL173.9736 mL
5 mM0.6959 mL3.4795 mL6.9589 mL34.7947 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Cyproheptadine | purchase Cyproheptadine | Cyproheptadine cost | order Cyproheptadine | Cyproheptadine chemical structure | Cyproheptadine in vivo | Cyproheptadine in vitro | Cyproheptadine formula | Cyproheptadine molecular weight